AtriCure (ATRC) Stock: Buy, Sell, or Hold?
$56.23
-0.03 (-0.06%)
▼
5d:
-14.2%
30d:
-1.13%
90d:
+29.28%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (54%)
Quality Score
37/100
Position
SLIGHTLY LOW
30-Day Fair Range
$55.32 – $61.12
Position: SLIGHTLY LOW
Forward P/E & Valuation
122.3x
STRETCHED
vs 99.7x historical avg
Wall Street Target
$64.89
+15.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$54.74 / $66.02
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ATRC is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ATRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.35
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$9.53
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRC is currently trading at $56.23, which is considered slightly low relative to its 30-day fair value range of $55.32 to $61.12. From a valuation perspective, the stock is trading at a premium (Forward PE: 122.2) compared to its historical average (99.7). At these levels, the market is pricing in 7.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is currently testing key support at $54.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATRC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $64.89 (+15.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is currently testing key support at $54.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATRC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $64.89 (+15.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$55.32 -
$61.12
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
53.8%
Trading Range & Key Levels
30-Day Trading Range
$55.32 -
$61.12
Current vs Trading Range
SLIGHTLY LOW
Support Level
$54.74
Resistance Level
$66.02
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($64.89)
- NEUTRAL: Trading at premium valuation - market expects 7.0% growth which is achievable
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
122.25
Wall Street Target
$64.89
(+15.3%)
Revenue Growth (YoY)
15.0%
Profit Margin
2.5%
Valuation Premium vs History
+7.0% premium
PE vs Historical
122.3 vs 99.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.0%
(market-implied from PE analysis)
1-Year Target
$60.20
(+7%)
2-Year Target
$64.41
(+15%)
3-Year Target
$68.92
(+23%)
3-Yr Target (if PE normalizes)
(PE: 122→100)
PE COMPRESSION
$56.21
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 122.3, Growth: 7.9%)
$70.58
(+26%)
Base:
(SPY PE: 19.9, Growth: 7.9%)
$11.47
(-80%)
Bear:
(PE: 16.9, Growth: 7.9%)
$9.75
(-83%)
Share ATRC Analysis
Share this live ATRC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ATRC)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 14, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism about the undervalued potential of $ATRC, despite its status as a small-cap company with few followers.
Key Retail Themes:
undervalued company
small-cap potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 1:55 PM ET
Data refreshes hourly during market hours. Next update: 2:55 PM
Data refreshes hourly during market hours. Next update: 2:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 40 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 44 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$471 | 50 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ATRC Research Pages
